Point72 Asia (Singapore)’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$151K Buy
21,567
+12,338
+134% +$85.8K 0.02% 362
2025
Q2
$56.4K Buy
+9,229
New +$61.4K 0.01% 572
2025
Q1
Sell
-1,465
Closed -$14.1K 1074
2024
Q4
$14.1K Sell
1,465
-19,160
-93% -$149K ﹤0.01% 706
2024
Q3
$122K Buy
20,625
+18,197
+749% +$121K 0.02% 493
2024
Q2
$16.8K Sell
2,428
-5,306
-69% -$37.3K ﹤0.01% 856
2024
Q1
$59.6K Buy
+7,734
New +$62.2K 0.02% 763

Other funds holding MDXG

Point72 Asia (Singapore)'s MDXG Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its MiMedx Group (MDXG) stake by 134% in Q3 2025, buying an estimated $85.8K and bringing the position to 21,567 shares worth $151K. The position accounts for 0.02% of the portfolio, ranked #362.

Point72 Asia (Singapore) first reported a position in MDXG in Q1 2024 and has held it in 6 quarters since. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.

  • Point72 Asia (Singapore) held 21,567 shares of MiMedx Group worth $151K as of Q3 2025.
  • Point72 Asia (Singapore) bought 12,338 MiMedx Group shares in Q3 2025, an estimated $85.8K.
  • MiMedx Group made up 0.02% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #362 holding.
  • Point72 Asia (Singapore) first reported a position in MiMedx Group in Q1 2024 and has held it in 6 quarters since.
  • 231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.